Fujikawa-Yamamoto K, Miyagoshi M, Yamagishi H
Hum Cell. 2013; 26(3):97-104.
PMID: 23460370
DOI: 10.1007/s13577-013-0063-x.
Fujikawa-Yamamoto K, Ota T, Miyagoshi M, Yamagishi H
Cell Prolif. 2012; 45(2):140-7.
PMID: 22288737
PMC: 6496692.
DOI: 10.1111/j.1365-2184.2011.00805.x.
Fujikawa-Yamamoto K, Miyagoshi M, Ota T, Yamagishi H
Hum Cell. 2011; 24(2):78-85.
PMID: 21573878
DOI: 10.1007/s13577-011-0017-0.
Fujikawa-Yamamoto K, Miyagoshi M, Luo X, Yamagishi H
Hum Cell. 2011; 24(1):13-20.
PMID: 21547691
DOI: 10.1007/s13577-010-0003-y.
Fujikawa-Yamamoto K, Miyagoshi M, Luo X, Yamagishi H
Cell Prolif. 2011; 44(2):111-9.
PMID: 21401752
PMC: 6496287.
DOI: 10.1111/j.1365-2184.2011.00734.x.
Different responses between diploid and tetraploid H1 embryonic stem cells appeared during long-term culturing in L15F10 medium without leukemia inhibitory factor.
Luo X, Fujikawa-Yamamoto K, Miyagoshi M, Yamagishi H
Hum Cell. 2010; 23(4):134-40.
PMID: 21166884
DOI: 10.1111/j.1749-0774.2010.00094.x.
Cell cycle, morphology and pluripotency of octaploid embryonic stem cells in comparison with those of tetraploid and diploid cells.
Fujikawa-Yamamoto K, Miyagoshi M, Yamagishi H
Hum Cell. 2009; 22(3):64-71.
PMID: 19624307
DOI: 10.1111/j.1749-0774.2009.00070.x.
Alteration and preservation of cellular characteristics in long-term culture of tetraploid H-1 (ES) cells.
Fujikawa-Yamamoto K, Miyagoshi M, Yamagishi H, Luo X
Hum Cell. 2008; 21(2):18-27.
PMID: 18397471
DOI: 10.1111/j.1749-0774.2008.00047.x.
Establishment of a tetraploid cell line from mouse H-1 (ES) cells highly polyploidized with demecolcine.
Fujikawa-Yamamoto K, Miyagoshi M, Yamagishi H
Cell Prolif. 2007; 40(3):327-37.
PMID: 17531078
PMC: 6496658.
DOI: 10.1111/j.1365-2184.2007.00442.x.
The reversion to diploid cells from established triploid V79 cells.
Miyagoshi M, Fujikawa-Yamamoto K
Cell Prolif. 2006; 39(5):421-8.
PMID: 16987143
PMC: 6496255.
DOI: 10.1111/j.1365-2184.2006.00398.x.
Establishment of a triploid V79 cell line from tetraploid cells obtained through polyploidization using K-252a.
Fujikawa-Yamamoto K, Yamagishi H, Miyagoshi M
Cell Prolif. 2002; 35(6):369-79.
PMID: 12427255
PMC: 6496678.
DOI: 10.1046/j.1365-2184.2002.00250.x.
Loss and recovery of transplantability of L-P59 cells.
Jurin M
In Vitro. 1973; 8(5):379-82.
PMID: 4695794
DOI: 10.1007/BF02619064.
Implications of tumor progression on clinical oncology.
Welch D, Tomasovic S
Clin Exp Metastasis. 1985; 3(3):151-88.
PMID: 3902300
DOI: 10.1007/BF01786761.
Loss of oncogenicity and concomitant increased immunogenicity of murine plasmacytoma cell lines.
SORENSON G, Pettengill O, Cate C
Am J Pathol. 1978; 90(3):565-82.
PMID: 629324
PMC: 2018238.
Resistance of neoplasms to immunological destruction: role of a macrophage chemotaxis inhibitor.
Pasternack G, Snyderman R, Pike M, Johnson R, Shin H
J Exp Med. 1978; 148(1):93-102.
PMID: 353219
PMC: 2184921.
DOI: 10.1084/jem.148.1.93.
